Lakefront Biotherapeutics | GLPG - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
argenx SE USD 165M 20M 2026-09
AstraZeneca USD 2.52B 2.73B 2026-06
Biogen USD 921.2M 23.9M 2026-09
Genmab DKK 84M 19M 2026-06
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.23B 163M 2026-09
GRIFOLS EUR 1.17B 90M 2026-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Incyte USD 108.74M 3.79M 2026-09
Merck EUR 2.27B 199M 2026-06
Neurocrine Biosciences USD 39.4M 25.6M 2026-06
Novartis USD 3.71B 251M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06
UCB EUR 1.07B 146M 2025-12
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06